RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Marketable securities, non-current

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥103.3B
P/E ratio
19.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 202520,042-9.34%
Mar 31, 202422,106-3.80%
Mar 31, 202322,979-10.60%
Mar 31, 202225,703+8.70%
Mar 31, 202123,645-8.59%
Mar 31, 202025,868-13.19%
Mar 31, 201929,799-41.24%
Mar 31, 201850,715+24.77%
Mar 31, 201740,647+21.46%
Mar 31, 201633,464+7.92%
Mar 31, 201531,008

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)